Ulsan University Hospital Opens Advanced Regenerative Medicine Center

Ulsan University Hospital has announced the opening of its Advanced Regenerative Medicine Center, a state-of-the-art facility dedicated to providing innovative treatment options for patients with rare and incurable diseases.

Advanced regenerative medicine is a cutting-edge medical technology that utilizes human cells to regenerate or restore the structure or function of the human body, or to treat or prevent diseases. This field has gained significant attention in recent years as a promising alternative for patients with limited treatment options.

Ulsan University Hospital was designated as an advanced regenerative medicine center by the Ministry of Health and Welfare in August of last year. Since then, the hospital has been conducting clinical research and applying regenerative medicine using stem cells, genes, and other technologies to treat incurable diseases under a strict and safe management system.

The hospital has also established a strategic partnership with Green Cross GC Cell to conduct research and production using mesenchymal stem cells derived from the umbilical cord and placenta. This collaboration is expected to accelerate the development of new treatments and therapies.

According to Director Seungwon Na, “The research being conducted at the Advanced Regenerative Medicine Center will provide new treatment opportunities for patients with rare and incurable diseases, and will greatly contribute to the treatment of incurable patients not only in the Ulsan region but also across the country.”

A symposium was held to commemorate the opening of the center, attended by prominent figures in the field of advanced regenerative medicine, including Ulsan University Hospital Biomedical Research Institute Director Lee Jong-soo, Advanced Regenerative Medicine Center Director Na Seung-won, and Asan Cell Therapy Center Director Professor Shin Dong-myeong.

The symposium provided a platform for experts to share their insights and experiences, and to discuss the future development of the center as a growth hub for the local bio industry.